Procter & Gamble (NYSE:PG) Stock Rating Lowered by Barclays

Procter & Gamble (NYSE:PG) was downgraded by analysts at Barclays from an “overweight” rating to an “equal weight” rating in a report released on Monday, Marketbeat Ratings reports. They currently have a $163.00 target price on the stock. Barclays‘s price objective would indicate a potential downside of 5.82% from the company’s previous close.

Several other equities research analysts also recently commented on the company. TD Cowen initiated coverage on Procter & Gamble in a report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 target price for the company. JPMorgan Chase & Co. upped their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Piper Sandler started coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price for the company. Finally, Jefferies Financial Group lowered Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price target for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. Nine equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $175.89.

Procter & Gamble Trading Down 0.1 %

Shares of NYSE PG opened at $173.07 on Monday. The company has a market cap of $408.47 billion, a price-to-earnings ratio of 28.28, a price-to-earnings-growth ratio of 3.76 and a beta of 0.41. The stock’s 50 day simple moving average is $171.01 and its 200 day simple moving average is $166.36. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. Procter & Gamble has a 12-month low of $141.45 and a 12-month high of $177.94.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same period last year, the firm earned $1.37 EPS. The firm’s revenue was down .1% compared to the same quarter last year. Equities research analysts expect that Procter & Gamble will post 6.97 EPS for the current year.

Insider Activity

In other news, CEO Jon R. Moeller sold 72,174 shares of Procter & Gamble stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the transaction, the chief executive officer now owns 263,158 shares in the company, valued at $45,002,649.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jon R. Moeller sold 72,174 shares of the firm’s stock in a transaction on Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the transaction, the chief executive officer now owns 263,158 shares of the company’s stock, valued at $45,002,649.58. The disclosure for this sale can be found here. Insiders sold a total of 375,553 shares of company stock valued at $63,829,141 over the last three months. Corporate insiders own 0.17% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Itau Unibanco Holding S.A. purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at $28,000. Fairway Wealth LLC bought a new position in Procter & Gamble in the 2nd quarter worth about $29,000. Ruedi Wealth Management Inc. raised its position in Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after purchasing an additional 77 shares in the last quarter. POM Investment Strategies LLC bought a new position in Procter & Gamble during the 2nd quarter worth about $34,000. Finally, Transcendent Capital Group LLC bought a new position in Procter & Gamble in the fourth quarter worth approximately $31,000. Institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.